Protocol for whole-mount preparation, clearing, and visualization of the adult zebrafish spinal cord structures Authors: Mariana Rebocho da Costa, Ana Ribeiro, Raquel Quitéria, Dalila Neves-Silva, Leonor Saúde Published: 2024 ABSTRACT SummaryThe vascular repair, a pivotal element of the spinal cord (SC) injury response, has been notably neglected in zebrafish research. Here, we detail the extraction and dissection of whole-mount zebrafish SCs and the optimized whole-mount immunofluorescence staining and clearing protocols for the visualization of SC structures, such as the vascular network. Additional downstream applications of these samples, from gelatin embedding to cryosectioning and tissue staining, can be done after clearing reversion and are also described in this work.For complete details on the use and execution of this protocol, please refer to Ribeiro et al.1Subject areas: Cell Biology, Microscopy, Model Organisms, Neuroscience Before you begin Certification and permission to work with animals need to be granted by the competent entities and by the institution where the work will be performed. Both male and female AB wild-type strain zebrafish (Danio rerio), aged between 3 to 9 months old, were used in this protocol. It is necessary to train SC extractions and dissections in this model to ensure sample integrity. All room temperature (RT) incubations used in this protocol were performed in a lab where the temperature varies between 22°C–25°C. Overnight incubations done in this protocol refer to time ranges between of 16–18 h. Whenever shaking or rotation is necessary, it is specifically indicated in the step. Before starting the protocol: 1.Have 4% Paraformaldehyde (PFA) at RT prepared to fix samples. Have 4% Paraformaldehyde (PFA) at RT prepared to fix samples. Note: Normally stored in aliquots at −20°C. 2.Have, at least, 100 mL of 1X Phosphate Sodium Buffer (PBS) solution at 4°C. Have, at least, 100 mL of 1X Phosphate Sodium Buffer (PBS) solution at 4°C. Note: Normally stored at RT. 3.Prepare specific clearing and whole-mount solutions that will be needed for this protocol (needed reagents and quantities are mentioned in materials and equipment section):a.Scale solutions2,3 (Scale A2 and S4) for the clearing protocol.b.Washing and whole-mount blocking solution for the whole-mount fluorescent immunohistochemistry. Prepare specific clearing and whole-mount solutions that will be needed for this protocol (needed reagents and quantities are mentioned in materials and equipment section):a.Scale solutions2,3 (Scale A2 and S4) for the clearing protocol.b.Washing and whole-mount blocking solution for the whole-mount fluorescent immunohistochemistry. a.Scale solutions2,3 (Scale A2 and S4) for the clearing protocol. Scale solutions2,3 (Scale A2 and S4) for the clearing protocol. b.Washing and whole-mount blocking solution for the whole-mount fluorescent immunohistochemistry. Washing and whole-mount blocking solution for the whole-mount fluorescent immunohistochemistry. 4.Other solutions needed for this protocol are mentioned in the materials and equipment section. Other solutions needed for this protocol are mentioned in the materials and equipment section. Institutional permissions Experiments received ethical approval by the Animal Welfare Body of the Instituto de Medicina Molecular João Lobo Antunes (ORBEA-iMM JLA), and were authorized by the Portuguese Competent Authority responsible for the protection of animals used for scientific purposes - Direção Geral de Alimentação e Veterinária (DGAV), conducted under the Project License 0421/000/000/2021. Scale A2 solution Timing: approximately 20 min Scale A2 solution is prepared according to Hama et al., 2011.2 5.Dissolve the urea in Milli-Q water (17.5% of the final volume of solution) and heat it to 25°C–30°C, while mixing, until it fully dissolves. Dissolve the urea in Milli-Q water (17.5% of the final volume of solution) and heat it to 25°C–30°C, while mixing, until it fully dissolves. 6.Add remaining reagents (Glycerol and Triton X-100), while mixing thoroughly. Add remaining reagents (Glycerol and Triton X-100), while mixing thoroughly. 7.Adjust with Milli-Q water to the final volume and store it at RT. Adjust with Milli-Q water to the final volume and store it at RT. Scale S4 solution Timing: approximately 4 h Note: This solution will be used as the clearing/refractive index matching solution as well as the immersion solution for imaging. It is always better to prepare a considerable volume (∼200 mL) and store a portion separately to always have it available for imaging purposes. Scale S4 solution is prepared according to Hama et al., 20153: CRITICAL: D-sorbitol and urea need to be dissolved separately. When joining them, the temperature of the D-sorbitol solution cannot exceed that of the urea solution otherwise the final Scale S4 solution will not have a clear/transparent aspect. 8.Add D-sorbitol to Milli-Q water (17.5% of the final volume of solution - e.g., 35 mL of 200 mL total volume) and microwaved the solution until it fully dissolves. Add D-sorbitol to Milli-Q water (17.5% of the final volume of solution - e.g., 35 mL of 200 mL total volume) and microwaved the solution until it fully dissolves. Note: We use a conventional 900 W microwave and heated the solution for 1 min and 30 s, stopping the microwave every 30 s and gently shaking the solution to mix the deposited powder. The solution will be hot so use heat-resistant gloves to avoid burning your hands. 9.Add urea to Milli-Q water (17.5% of the final volume of solution) and heat it to 25°C–30°C, while mixing, until it fully dissolves. Add urea to Milli-Q water (17.5% of the final volume of solution) and heat it to 25°C–30°C, while mixing, until it fully dissolves. Note: Make sure the temperature of the solution does not go above 30°C otherwise, after mixing all the reagents, the final Scale S4 solution will not have a clear/transparent aspect. 10.Allow both solutions to cool down to RT before mixing them. Allow both solutions to cool down to RT before mixing them. Note: If left to cool down at the bench, the D-sorbitol solution might take 2–3 h to reach room temperature. 11.Add remaining reagents (Glycerol, Triton X-100 and Dimethyl sulfoxide (DMSO)), while mixing thoroughly. Add remaining reagents (Glycerol, Triton X-100 and Dimethyl sulfoxide (DMSO)), while mixing thoroughly. 12.Confirm the final volume of the solution and adjust with Milli-Q water if necessary. Store it at 4°C until needed. Confirm the final volume of the solution and adjust with Milli-Q water if necessary. Store it at 4°C until needed. Note: When mixing all the reagents, small bubbles might be formed, giving the solution a hazy appearance. Let the solution rest at 4°C for 2 h. The solution should have a clear appearance afterward. If not, discard the solution. Note: This solution can be prepared in a more diluted state, for example instead of adding water to the final volume, add 200 mL of Milli-Q water and keep all the other reagents in the same quantities. This solution will always have a clear appearance. Since the proportions of the reagents are kept the same, it is possible to achieve sample clearing but it will take longer to reach the same level of transparency. It is therefore advisable to use the normal/more concentrated version to be able to achieve the timings and results detailed in this protocol. Washing and whole-mount blocking solutions Timing: approximately 30 min 13.To prepare the washing solution, use a 250 mL dark reagent bottle or cover a transparent 250 mL bottle with aluminum foil, to protect it from light. To prepare the washing solution, use a 250 mL dark reagent bottle or cover a transparent 250 mL bottle with aluminum foil, to protect it from light. 14.Add DMSO and Triton X-100 to 1X PBS. Add DMSO and Triton X-100 to 1X PBS. Note: The minimum advisable volume to prepare is 200 mL, since this solution will be used as a washing solution but also will be necessary for the whole-mount blocking solution, as described below. 15.To prepare whole-mount blocking solution:a.Transfer the required volume of the washing solution to another reagent bottle.Note: The minimum advisable volume to prepare is 50 mL, since this solution will be used for sample blocking but also will be necessary for the antibody solutions.b.Add 1% (w/v) Bovine Serum Albumin (BSA) and keep the solution at 4°C until it dissolves.Note: No shaking is needed to dissolve the BSA.c.Aliquot solution in 15 mL falcons and store it at −20°C. To prepare whole-mount blocking solution:a.Transfer the required volume of the washing solution to another reagent bottle.Note: The minimum advisable volume to prepare is 50 mL, since this solution will be used for sample blocking but also will be necessary for the antibody solutions.b.Add 1% (w/v) Bovine Serum Albumin (BSA) and keep the solution at 4°C until it dissolves.Note: No shaking is needed to dissolve the BSA.c.Aliquot solution in 15 mL falcons and store it at −20°C. a.Transfer the required volume of the washing solution to another reagent bottle.Note: The minimum advisable volume to prepare is 50 mL, since this solution will be used for sample blocking but also will be necessary for the antibody solutions. Transfer the required volume of the washing solution to another reagent bottle.Note: The minimum advisable volume to prepare is 50 mL, since this solution will be used for sample blocking but also will be necessary for the antibody solutions. Note: The minimum advisable volume to prepare is 50 mL, since this solution will be used for sample blocking but also will be necessary for the antibody solutions. b.Add 1% (w/v) Bovine Serum Albumin (BSA) and keep the solution at 4°C until it dissolves.Note: No shaking is needed to dissolve the BSA. Add 1% (w/v) Bovine Serum Albumin (BSA) and keep the solution at 4°C until it dissolves.Note: No shaking is needed to dissolve the BSA. Note: No shaking is needed to dissolve the BSA. c.Aliquot solution in 15 mL falcons and store it at −20°C. Aliquot solution in 15 mL falcons and store it at −20°C. Key resources table REAGENT or RESOURCESOURCEIDENTIFIERAntibodiesRabbit anti-GFP (1:500)InvitrogenCat# A6455; RRID:AB_221570Mouse anti-acetylated tubulin (1:500)Sigma-AldrichCat#T7451; RRID:AB_609894Rabbit anti-GFAP (1:500)Agilent DakoCat# Z0334; RRID:AB_10013382Alexa Fluor 633 goat anti-mouse IgG (1:500)InvitrogenCat# A21050; RRID:AB_2535718Alexa Fluor 488 goat anti-rabbit IgG (1:500–1,000)InvitrogenCat# A11008; RRID:AB_143165Chemicals, peptides, and recombinant proteinsPhosphate-buffered saline (PBS) 1xSigma-AldrichCat#P4417Paraformaldehyde (PFA)Sigma-AldrichCat#8.18715Bovine serum albumin (BSA)NZYtechCat#MB04602NuSieve GTG agaroseLonzaCat#50080Triton X-100Sigma-AldrichCat#T8787Dimethyl sulfoxide (DMSO)VWRCat#VWRC0231UreaSigma-AldrichCat#U1250GlycerolSigma-AldrichCat#49767D-SorbitolSigma-AldrichCat#S6021TO-PRO-3 iodide (642/661) (1:1,000)Thermo Fisher ScientificCat#T3605Paraformaldehyde (PFA)MerckCat#MERC8.18715.10004′,6-diamidino-2-phenylindole (DAPI)Sigma-AldrichCat#D9564MowiolCalbiochemCat#475904Tricaine methanesulfonatePharmaQN/ANaH2PO4.2H2OMerckCat#106342Na2HPO4.7H2OSigma-AldrichCat#S9390Sodium hydroxideMerckCat#106498Sodium azideSigma-AldrichCat#S202Tris(hydroxymethyl)aminomethaneMerckCat# 108382Hydrochloric acid fuming 37%MerckCat# 100317GelatinSigma-AldrichCat#G6155IsopentaneVWRCat#24872.298SucroseSigma-AldrichCat#S9378Harris hematoxylinBio-OpticaCat#05-06004/LAlcoholic eosin Y solutionSigma-AldrichCat#HT110132BioClear - xylene for histologyBioGnostCat#BC-1LEthanol absolute ≥99.5%AGACat#4.006.16.00.00Ethanol 96%AGACat#10100602Ethanol 70%AGACat#10300602Entellan new mounting mediumVWRCat# MERC1.00869.0500Experimental models: Organisms/strainsDanio rerio: Tg(kdrl:EGFP)s843Jin et al.4ZFIN: ZDB-TGCONSTRCT-070117-47Danio rerio: Tg(kdrl:HRAS-mCherry)s896Chi et al.5ZFIN: ZDB-TGCONSTRCT-081212-4Danio rerio: Tg(kdrl:NLS-mCherry)is4Wang Y et al.6ZFIN: ZDB-TGCONSTRCT-110127-22Danio rerio: Tg(mpeg1:EGFP)gl22TgEllet et al.7ZFIN: ZDB-TGCONSTRCT-120117-1Software and algorithmsZENZeisshttps://www.zeiss.com/microscopy/en/products/software/zeiss-zen.htmlFiji/ImageJ ∗Schindelin et al.8https://imagej.net/RStudio ∗Posit PBChttps://posit.co/downloads/Illustrator CS6 ∗Adobehttps://www.adobe.com/pt/products/illustrator.htmlOtherDumont #55 forcepsFine Science ToolsCat#11255-20Vannas-Tübingen spring scissorsFine Science ToolsCat#15003-0822.5° cutting angle micro knives - plastic handleFine Science ToolsCat#10316-14Scalpel bladesSwann-MortonCat#233-003090 mm Petri dishVWRCat#391-05591,5 mL Eppendorf Safe-Lock tubesEppendorfCat#003012008615 mL FalconsCorningCat#43079150 mL FalconsCorningCat#430829Staining jarFisher ScientificCat# 10284922Super PAP pen liquid blockerTed Pella Inc.Cat#22309Simax reagent glass bottle 250 mLScientific Laboratory SuppliesCat#BOT53060Simax reagent glass bottle 500 mLScientific Laboratory SuppliesCat#BOT5308Filter Steritop 500 mL 45 mm neck size 0.22 μL PESMerck/MilliporeCat#S2GPT05RECryomoldSimport ScientificCat#M475-2 and Cat#M475-3Slide boxesVWRCat# 631-1500Epredia SuperFrost Plus adhesion slidesFisher ScientificCat#J1800AMNZEpredia coverslip 24 × 60 mm #1.5 (0.16–0.19 mm)Fisher ScientificCat#BB02400600SC13MNZ0Opaque cylindric boxes for incubationsRochePackaging box from product Cat#11093274910Zeiss Lightsheet capillaries and plungers – size 1Zeiss/N/AZeiss Lightsheet Z.1ZeissN/AZeiss LSM 880ZeissN/AZeiss Axio Zoom.V16 fluorescent stereoscopeZeissN/AZeiss Stemi 508 stereoscopeZeissN/ANanoZoomer-SQ digital slide scannerHamamatsuN/ARotating mixersCAT (ZIPPERER GMBH)Model RM5-30VShaker with angled platformHeidolph InstrumentsSimilar to Model 10599711IncubatorMemmertModel UNB400∗ The software here listed were used for the figures presented in this protocol and are not necessary for the execution of the protocol. Similar software can be used for the same purposes. ∗ The software here listed were used for the figures presented in this protocol and are not necessary for the execution of the protocol. Similar software can be used for the same purposes. Materials and equipment Scale S4 (pH 7.9–8.9; theoretical refractive index at 27°C: 1.439)ReagentFinal concentrationAmountD-sorbitol40% w/v80 gUrea4 M48.048 gGlycerol10% w/v20 gTriton X-1000.2% w/v0.4 gDimethyl sulfoxide (DMSO)15% v/v30 mLMilli-Q H2ON/ATo final VTotalN/A200 mLSolution can be stored short term at RT (low volume) or for longer periods at 2°C–10°C (bigger volumes up to half a year). Scale S4 (pH 7.9–8.9; theoretical refractive index at 27°C: 1.439) Solution can be stored short term at RT (low volume) or for longer periods at 2°C–10°C (bigger volumes up to half a year). Alternatives: Solution can be purchased from Fujifilm Wako Chemicals (SCALEVIEW-S4 - https://labchem-wako.fujifilm.com/us/product/detail/W01W0119-1856.html). Scale A2ReagentFinal concentrationAmountUrea4 M48.048 gGlycerol10% w/v20 gTriton X-1000.1% w/v0.2 gMilli-Q H2ON/ATo final VTotalN/A200 mLSolution can be stored, up to half a year, below 25°C. Scale A2 Solution can be stored, up to half a year, below 25°C. Alternatives: Solution can be purchased from Fujifilm Wako Chemicals (SCALEVIEW-A2 - https://labchem-wako.fujifilm.com/us/product/detail/W01W0119-1845.html). Washing solutionReagentFinal concentrationAmountDimethyl sulfoxide (DMSO)10% v/v20 mLTriton X-1000.2% v/v0.4 mL1X PBSN/ATo final VTotalN/A200 mLSolution can be stored at RT for 3 months, protected from light. Washing solution Solution can be stored at RT for 3 months, protected from light. Whole-mount blocking solutionReagentFinal concentrationAmountDimethyl sulfoxide (DMSO)10% v/v10 mLTriton X-1000.2% v/v0.2 mLBovine Serum Albumin (BSA)1% w/v1 g1X PBSN/ATo final VTotalN/A100 mLSolution is aliquoted in 15 mL falcons and stored at −20°C, for up to 2 months. Whole-mount blocking solution Solution is aliquoted in 15 mL falcons and stored at −20°C, for up to 2 months. 1 M phosphate buffer (PB, pH 7.2)ReagentFinal concentrationAmount1 M NaH2PO4.2H2O0.28 M14 mL1 M Na2HPO4.7H2O0.72 M36 mLMilli-Q H2ON/ATo final VTotalN/A50 mLSolution can be stored at −20°C, for up to 6 months. 1 M phosphate buffer (PB, pH 7.2) Solution can be stored at −20°C, for up to 6 months. 4% PFA (pH 7.4)ReagentFinal concentrationAmountParaformaldehyde (PFA)4% w/v20 g10X Phosphate Sodium Buffer (PBS)1X50 mL10 M Sodium Hydroxide0.4 mM20 μLMilli-Q H2ON/ATo final VTotalN/A500 mLSolution is aliquoted in 15 mL falcons and stored at −20°C, for up to 3 months. 4% PFA (pH 7.4) Solution is aliquoted in 15 mL falcons and stored at −20°C, for up to 3 months. Note: Prepare solution on a stir plate in a chemical hood and always keep it inside the hood until the filtration step. Warm 400 mL of water to, maximum, 60°C and maintain temperature to dissolve powder. Add the remaining reagents and adjust the pH to 7.4. Add water to the desired final volume and filter the solution (type of filter bottle). Tricaine (25X, stock solution)ReagentFinal concentrationAmountTricaine15 mM4 g1 M Tris HCL pH 820 mM20 mLMilli-Q H2ON/ATo final VTotalN/A1 LSolution is stored at 4°C or aliquotes and kept at −20°C, for up to 2 or 6 months, respectively, while protected from light. Tricaine (25X, stock solution) Solution is stored at 4°C or aliquotes and kept at −20°C, for up to 2 or 6 months, respectively, while protected from light. Note: After mixing all reagents, check if the stock solution's pH is between 7 and 8 and adjust, if needed. To prepare a 1X Tricaine working solution, dilute 1 mL of stock solution in 25 mL total volume of Aquatics System’s water. Sucrose solutionsReagentFinal concentrationAmountSucrose15% or 30%7.5 g or 15 g1 M Phosphate Buffer0.12 M6 mLMilli-Q H2ON/ATo final VTotalN/A50 mLSolutions are aliquoted in 15 mL falcons and stored at −20°C, for up to 2 months. Sucrose solutions Solutions are aliquoted in 15 mL falcons and stored at −20°C, for up to 2 months. 7.5% gelatin solutionReagentFinal concentrationAmountGelatin7.5%15 gSucrose15%30 g1 M Phosphate Buffer (PB)0.12 M24 mLMilli-Q H2ON/ATo final VTotalN/A200 mLSolutions are aliquoted in 50 mL falcons and stored at −20°C, for up to 2 months. 7.5% gelatin solution Solutions are aliquoted in 50 mL falcons and stored at −20°C, for up to 2 months. Note: To prepare gelatin solution, use pre-warmed Milli-Q H2O (∼50°C). Each Falcon is a one-use only solution, do not store again after use. Mowiol mediumReagentFinal concentrationAmountMowiol14.5% w/v2.9 gGlycerol30% v/v6 gMilli-Q H2ON/A6 mL0.2 M Tris pH 8.50.12 M12 mLTotalN/A∼20 mLSolution is aliquoted in 1.5 mL tubes and stored at −20°C, for up to 3 months. Mowiol medium Solution is aliquoted in 1.5 mL tubes and stored at −20°C, for up to 3 months. Note: Join all reagents by the order above described while mixing and maintaining a stable temperature of 55°C Step-by-step method details Sample preparation | spinal cord extraction & dissection Timing: 4 h to 1 day In developing zebrafish, the SC is easily visualized due to the animal’s transparency. Contrary to this, in the adult stage, the SC must be removed from the animal to ensure the best whole-mount processing and visualization. The protocol below details all the material and steps needed to ensure sample integrity, including SC extraction and dissection from the vertebral column (VC). Note: All the extractions and dissections were performed by right-handed users. Tool positioning and sample orientation might need to be adjusted for left-handed people. 1.Sacrifice an adult zebrafish by anesthetic overdose (15 mM Tricaine) followed by decapitation. Sacrifice an adult zebrafish by anesthetic overdose (15 mM Tricaine) followed by decapitation. Note: The euthanasia method used is in accordance with the methods authorized by local authorities and may change depending on regional laws. 2.Under a stereoscope, expose VC of the fish (Figure 1A):a.Transfer the animal to a petri dish lid, with its rostral part to the right and right side upwards.Optional: For inexperienced users, this protocol can be done with the petri dish on top of a malleable cold pack (normally used to ship samples) to avoid sample deterioration.Note: For extraction, we place the animal right side up since, in SC injured animals, the surgical procedure is done with the animal in the opposite position (left side up). By placing it this way, we prevent unwanted damage to that SC area when opening the fish for extraction.b.Secure the animal by the tail, using the left forceps. Remove the scales of the area to be cut, in a caudal to rostral motion along the body of fish, using the 22.5° angle micro knife.c.With the knife, puncture the skin along the first yellow stripe of the animal.Note: The VC, in most animals, will be directly below this stripe. In animals with different pigmentation patterns, the top limit of the opercular opening can be used as the closest anatomical landmark.d.Using the scissors, cut along the punctured path, starting caudally.e.Remove all the muscle covering the VC by cutting along the column’s length, with the scissors parallel to the vertebra. The VC should be exposed as seen in Figure 1Ai.Note: The zebrafish SC has pigmented cells (melanophores) on the dorsal side (except in mutants with pigmentation defects, such as the casper line9), which facilitates its identification and orientation. Under a stereoscope, expose VC of the fish (Figure 1A):a.Transfer the animal to a petri dish lid, with its rostral part to the right and right side upwards.Optional: For inexperienced users, this protocol can be done with the petri dish on top of a malleable cold pack (normally used to ship samples) to avoid sample deterioration.Note: For extraction, we place the animal right side up since, in SC injured animals, the surgical procedure is done with the animal in the opposite position (left side up). By placing it this way, we prevent unwanted damage to that SC area when opening the fish for extraction.b.Secure the animal by the tail, using the left forceps. Remove the scales of the area to be cut, in a caudal to rostral motion along the body of fish, using the 22.5° angle micro knife.c.With the knife, puncture the skin along the first yellow stripe of the animal.Note: The VC, in most animals, will be directly below this stripe. In animals with different pigmentation patterns, the top limit of the opercular opening can be used as the closest anatomical landmark.d.Using the scissors, cut along the punctured path, starting caudally.e.Remove all the muscle covering the VC by cutting along the column’s length, with the scissors parallel to the vertebra. The VC should be exposed as seen in Figure 1Ai.Note: The zebrafish SC has pigmented cells (melanophores) on the dorsal side (except in mutants with pigmentation defects, such as the casper line9), which facilitates its identification and orientation. a.Transfer the animal to a petri dish lid, with its rostral part to the right and right side upwards.Optional: For inexperienced users, this protocol can be done with the petri dish on top of a malleable cold pack (normally used to ship samples) to avoid sample deterioration.Note: For extraction, we place the animal right side up since, in SC injured animals, the surgical procedure is done with the animal in the opposite position (left side up). By placing it this way, we prevent unwanted damage to that SC area when opening the fish for extraction. Transfer the animal to a petri dish lid, with its rostral part to the right and right side upwards.Optional: For inexperienced users, this protocol can be done with the petri dish on top of a malleable cold pack (normally used to ship samples) to avoid sample deterioration.Note: For extraction, we place the animal right side up since, in SC injured animals, the surgical procedure is done with the animal in the opposite position (left side up). By placing it this way, we prevent unwanted damage to that SC area when opening the fish for extraction. Optional: For inexperienced users, this protocol can be done with the petri dish on top of a malleable cold pack (normally used to ship samples) to avoid sample deterioration. Note: For extraction, we place the animal right side up since, in SC injured animals, the surgical procedure is done with the animal in the opposite position (left side up). By placing it this way, we prevent unwanted damage to that SC area when opening the fish for extraction. b.Secure the animal by the tail, using the left forceps. Remove the scales of the area to be cut, in a caudal to rostral motion along the body of fish, using the 22.5° angle micro knife. Secure the animal by the tail, using the left forceps. Remove the scales of the area to be cut, in a caudal to rostral motion along the body of fish, using the 22.5° angle micro knife. c.With the knife, puncture the skin along the first yellow stripe of the animal.Note: The VC, in most animals, will be directly below this stripe. In animals with different pigmentation patterns, the top limit of the opercular opening can be used as the closest anatomical landmark. With the knife, puncture the skin along the first yellow stripe of the animal.Note: The VC, in most animals, will be directly below this stripe. In animals with different pigmentation patterns, the top limit of the opercular opening can be used as the closest anatomical landmark. Note: The VC, in most animals, will be directly below this stripe. In animals with different pigmentation patterns, the top limit of the opercular opening can be used as the closest anatomical landmark. d.Using the scissors, cut along the punctured path, starting caudally. Using the scissors, cut along the punctured path, starting caudally. e.Remove all the muscle covering the VC by cutting along the column’s length, with the scissors parallel to the vertebra. The VC should be exposed as seen in Figure 1Ai.Note: The zebrafish SC has pigmented cells (melanophores) on the dorsal side (except in mutants with pigmentation defects, such as the casper line9), which facilitates its identification and orientation. Remove all the muscle covering the VC by cutting along the column’s length, with the scissors parallel to the vertebra. The VC should be exposed as seen in Figure 1Ai.Note: The zebrafish SC has pigmented cells (melanophores) on the dorsal side (except in mutants with pigmentation defects, such as the casper line9), which facilitates its identification and orientation. Note: The zebrafish SC has pigmented cells (melanophores) on the dorsal side (except in mutants with pigmentation defects, such as the casper line9), which facilitates its identification and orientation. 3.Detach the VC from its surroundings.a.Place the scissors below the column, cutting parallel along its length.Note: Do not worry about removing all muscle surrounding the left side of the VC in this step; this can be done afterward, when the sample is removed from the animal.b.Cut above the VC, preserving the neural arches and without damaging the SC.c.Transect the VC caudally, extracting as much of it as possible.d.Remove the sample from the animal (Figure 1Aii). Detach the VC from its surroundings.a.Place the scissors below the column, cutting parallel along its length.Note: Do not worry about removing all muscle surrounding the left side of the VC in this step; this can be done afterward, when the sample is removed from the animal.b.Cut above the VC, preserving the neural arches and without damaging the SC.c.Transect the VC caudally, extracting as much of it as possible.d.Remove the sample from the animal (Figure 1Aii). a.Place the scissors below the column, cutting parallel along its length.Note: Do not worry about removing all muscle surrounding the left side of the VC in this step; this can be done afterward, when the sample is removed from the animal. Place the scissors below the column, cutting parallel along its length.Note: Do not worry about removing all muscle surrounding the left side of the VC in this step; this can be done afterward, when the sample is removed from the animal. Note: Do not worry about removing all muscle surrounding the left side of the VC in this step; this can be done afterward, when the sample is removed from the animal. b.Cut above the VC, preserving the neural arches and without damaging the SC. Cut above the VC, preserving the neural arches and without damaging the SC. c.Transect the VC caudally, extracting as much of it as possible. Transect the VC caudally, extracting as much of it as possible. d.Remove the sample from the animal (Figure 1Aii). Remove the sample from the animal (Figure 1Aii). 4.Place the sample with its right side downwards and cut the remaining muscle. Place the sample with its right side downwards and cut the remaining muscle. Note: By removing as much muscle from both right and left sides of the sample, we prevent sample curling/bending during fixation. Troubleshooting 1. 5.Trim the sample to the desired length (> 8 mm, as shown in Figure 1Aiii). Trim the sample to the desired length (> 8 mm, as shown in Figure 1Aiii). 6.Place the sample in 4% Paraformaldehyde (PFA), inside 1.5 mL tubes:CRITICAL: PFA is toxic. Perform all steps using PFA, including preparation of collection tubes with 4% PFA, in a fume hood. Avoid inhalation and contact with skin or eyes.Note: From this point onwards, since the samples will be stored in the same 1.5 mL tube for all of the steps and only the solutions are changed, it is important to properly label each tube.a.Protect the samples from light by placing them inside of a cylindrical opaque box or wrapped in aluminum foil.b.Incubate for 2 h at room temperature (RT) or overnight (16–18 h) at 4°C.Note: To avoid sample bending, incubate the samples horizontally. Place the sample in 4% Paraformaldehyde (PFA), inside 1.5 mL tubes:CRITICAL: PFA is toxic. Perform all steps using PFA, including preparation of collection tubes with 4% PFA, in a fume hood. Avoid inhalation and contact with skin or eyes.Note: From this point onwards, since the samples will be stored in the same 1.5 mL tube for all of the steps and only the solutions are changed, it is important to properly label each tube.a.Protect the samples from light by placing them inside of a cylindrical opaque box or wrapped in aluminum foil.b.Incubate for 2 h at room temperature (RT) or overnight (16–18 h) at 4°C.Note: To avoid sample bending, incubate the samples horizontally. CRITICAL: PFA is toxic. Perform all steps using PFA, including preparation of collection tubes with 4% PFA, in a fume hood. Avoid inhalation and contact with skin or eyes. Note: From this point onwards, since the samples will be stored in the same 1.5 mL tube for all of the steps and only the solutions are changed, it is important to properly label each tube. a.Protect the samples from light by placing them inside of a cylindrical opaque box or wrapped in aluminum foil. Protect the samples from light by placing them inside of a cylindrical opaque box or wrapped in aluminum foil. b.Incubate for 2 h at room temperature (RT) or overnight (16–18 h) at 4°C.Note: To avoid sample bending, incubate the samples horizontally. Incubate for 2 h at room temperature (RT) or overnight (16–18 h) at 4°C.Note: To avoid sample bending, incubate the samples horizontally. Note: To avoid sample bending, incubate the samples horizontally. 7.After fixation, remove the 4% PFA solution and wash the samples in 1X PBS, for 5 min 3x at RT, on a shaker. After fixation, remove the 4% PFA solution and wash the samples in 1X PBS, for 5 min 3x at RT, on a shaker. 8.Transfer the samples to a petri dish with cold 1X PBS and dissect SC from VC (Figure 1B):a.Gently cut any excess muscle left on both sides of the sample and between the neural arches.b.Place the sample with its right side downwards (rostral part to the left, like shown in Figure 1Biv).c.Remove neural arches, starting caudally (Figure 1Bv):i.Secure the vertebrae with the left forceps and, with the right one, grab the neural arch that is attached to it.ii.The neural arch can be removed by pulling it in the opposite direction or by finding its attachment to the vertebrae, gently breaking it and removing the detached arch.CRITICAL: For injured samples, the second method of removing the arch is preferred to ensure the integrity of the injury site.d.After the removal of all arches, carefully insert the right forceps below the SC, starting caudally, and gently lift the SC from each vertebra (Figure 1Bvi).Note: For this step, a half forceps (separated from an old, damaged forceps that is not usable for injuries or extractions) can substitute the forceps in the right hand.CRITICAL: For injured samples, before reaching the injury site, repeat the lifting process for the SC rostral to the lesion. Then carefully remove the injury site from the vertebrae it is attached to.Note: Pulling of the neural arches often results in partial removal of the melanophores present in the dorsal part of the spinal cord. Although not usual, in samples where melanophores are still covering the region to be imaged, it might be necessary to remove them since they can block the passage of light during acquisition (this can be done during the Sample Clearing and Visualization Section).e.After SC dissection, place the sample inside the original tubes, filled with 1X PBS, at 4°C. Store the tubes wrapped in aluminum foil or in labeled cylindrical opaque container, before proceeding with the protocol.CRITICAL: Sample should not be stored for more than a week to ensure the best results and PBS should be switched every 2–3 days. Transfer the samples to a petri dish with cold 1X PBS and dissect SC from VC (Figure 1B):a.Gently cut any excess muscle left on both sides of the sample and between the neural arches.b.Place the sample with its right side downwards (rostral part to the left, like shown in Figure 1Biv).c.Remove neural arches, starting caudally (Figure 1Bv):i.Secure the vertebrae with the left forceps and, with the right one, grab the neural arch that is attached to it.ii.The neural arch can be removed by pulling it in the opposite direction or by finding its attachment to the vertebrae, gently breaking it and removing the detached arch.CRITICAL: For injured samples, the second method of removing the arch is preferred to ensure the integrity of the injury site.d.After the removal of all arches, carefully insert the right forceps below the SC, starting caudally, and gently lift the SC from each vertebra (Figure 1Bvi).Note: For this step, a half forceps (separated from an old, damaged forceps that is not usable for injuries or extractions) can substitute the forceps in the right hand.CRITICAL: For injured samples, before reaching the injury site, repeat the lifting process for the SC rostral to the lesion. Then carefully remove the injury site from the vertebrae it is attached to.Note: Pulling of the neural arches often results in partial removal of the melanophores present in the dorsal part of the spinal cord. Although not usual, in samples where melanophores are still covering the region to be imaged, it might be necessary to remove them since they can block the passage of light during acquisition (this can be done during the Sample Clearing and Visualization Section).e.After SC dissection, place the sample inside the original tubes, filled with 1X PBS, at 4°C. Store the tubes wrapped in aluminum foil or in labeled cylindrical opaque container, before proceeding with the protocol.CRITICAL: Sample should not be stored for more than a week to ensure the best results and PBS should be switched every 2–3 days. a.Gently cut any excess muscle left on both sides of the sample and between the neural arches. Gently cut any excess muscle left on both sides of the sample and between the neural arches. b.Place the sample with its right side downwards (rostral part to the left, like shown in Figure 1Biv). Place the sample with its right side downwards (rostral part to the left, like shown in Figure 1Biv). c.Remove neural arches, starting caudally (Figure 1Bv):i.Secure the vertebrae with the left forceps and, with the right one, grab the neural arch that is attached to it.ii.The neural arch can be removed by pulling it in the opposite direction or by finding its attachment to the vertebrae, gently breaking it and removing the detached arch.CRITICAL: For injured samples, the second method of removing the arch is preferred to ensure the integrity of the injury site. Remove neural arches, starting caudally (Figure 1Bv):i.Secure the vertebrae with the left forceps and, with the right one, grab the neural arch that is attached to it.ii.The neural arch can be removed by pulling it in the opposite direction or by finding its attachment to the vertebrae, gently breaking it and removing the detached arch.CRITICAL: For injured samples, the second method of removing the arch is preferred to ensure the integrity of the injury site. i.Secure the vertebrae with the left forceps and, with the right one, grab the neural arch that is attached to it. Secure the vertebrae with the left forceps and, with the right one, grab the neural arch that is attached to it. ii.The neural arch can be removed by pulling it in the opposite direction or by finding its attachment to the vertebrae, gently breaking it and removing the detached arch.CRITICAL: For injured samples, the second method of removing the arch is preferred to ensure the integrity of the injury site. The neural arch can be removed by pulling it in the opposite direction or by finding its attachment to the vertebrae, gently breaking it and removing the detached arch.CRITICAL: For injured samples, the second method of removing the arch is preferred to ensure the integrity of the injury site. CRITICAL: For injured samples, the second method of removing the arch is preferred to ensure the integrity of the injury site. d.After the removal of all arches, carefully insert the right forceps below the SC, starting caudally, and gently lift the SC from each vertebra (Figure 1Bvi).Note: For this step, a half forceps (separated from an old, damaged forceps that is not usable for injuries or extractions) can substitute the forceps in the right hand.CRITICAL: For injured samples, before reaching the injury site, repeat the lifting process for the SC rostral to the lesion. Then carefully remove the injury site from the vertebrae it is attached to.Note: Pulling of the neural arches often results in partial removal of the melanophores present in the dorsal part of the spinal cord. Although not usual, in samples where melanophores are still covering the region to be imaged, it might be necessary to remove them since they can block the passage of light during acquisition (this can be done during the Sample Clearing and Visualization Section). After the removal of all arches, carefully insert the right forceps below the SC, starting caudally, and gently lift the SC from each vertebra (Figure 1Bvi).Note: For this step, a half forceps (separated from an old, damaged forceps that is not usable for injuries or extractions) can substitute the forceps in the right hand.CRITICAL: For injured samples, before reaching the injury site, repeat the lifting process for the SC rostral to the lesion. Then carefully remove the injury site from the vertebrae it is attached to.Note: Pulling of the neural arches often results in partial removal of the melanophores present in the dorsal part of the spinal cord. Although not usual, in samples where melanophores are still covering the region to be imaged, it might be necessary to remove them since they can block the passage of light during acquisition (this can be done during the Sample Clearing and Visualization Section). Note: For this step, a half forceps (separated from an old, damaged forceps that is not usable for injuries or extractions) can substitute the forceps in the right hand. CRITICAL: For injured samples, before reaching the injury site, repeat the lifting process for the SC rostral to the lesion. Then carefully remove the injury site from the vertebrae it is attached to. Note: Pulling of the neural arches often results in partial removal of the melanophores present in the dorsal part of the spinal cord. Although not usual, in samples where melanophores are still covering the region to be imaged, it might be necessary to remove them since they can block the passage of light during acquisition (this can be done during the Sample Clearing and Visualization Section). e.After SC dissection, place the sample inside the original tubes, filled with 1X PBS, at 4°C. Store the tubes wrapped in aluminum foil or in labeled cylindrical opaque container, before proceeding with the protocol.CRITICAL: Sample should not be stored for more than a week to ensure the best results and PBS should be switched every 2–3 days. After SC dissection, place the sample inside the original tubes, filled with 1X PBS, at 4°C. Store the tubes wrapped in aluminum foil or in labeled cylindrical opaque container, before proceeding with the protocol.CRITICAL: Sample should not be stored for more than a week to ensure the best results and PBS should be switched every 2–3 days. CRITICAL: Sample should not be stored for more than a week to ensure the best results and PBS should be switched every 2–3 days. Spinal cord preparation for downstream applications (A) When using adult zebrafish, the vertebral column must be extracted from the animal (i, ii and iii) before fixation. (B) After fixation, the spinal cord is dissected from the vertebrae (iv, v and vi) before being used directly in clearing protocols or, when needed, in immunofluorescence staining protocols. Whole-mount tissue staining | immunofluorescence and nuclear labeling Timing: ∼1 week For samples where there is the need to amplify the signal of transgenic fluorophores or to label specific structures, whole SC staining can be done before clearing. In this case, we optimized a protocol for immunofluorescence staining of intracellular EGFP. Additionally, nuclear staining with TO-PRO-3 can also be performed individually or at the end of the immunostaining protocol. Note: For all incubations and washes, samples were placed in a cylindrical opaque container while on the roller, to protect them from light. Antibodies and TO-PRO-3 concentrations are mentioned in the key resources table section. CRITICAL: Samples can be hidden inside the cap of the 1,5 mL tube or can be aspirated while switching the solutions. To not damage or lose samples, always make sure they are visible and inside the solution, before gently removing the liquid. Ensure that the SCs are submerged and that tube caps are well closed before starting incubations. 9.After SC dissection, place the sample in 1 mL of whole-mount blocking solution (WMB) for 1 day at RT, on a roller (20 rpm). After SC dissection, place the sample in 1 mL of whole-mount blocking solution (WMB) for 1 day at RT, on a roller (20 rpm). 10.Dilute the primary antibody in WMB and incubate the sample with 500 μL for 2 days at 4°C, on a roller Troubleshooting 2 and 3. Dilute the primary antibody in WMB and incubate the sample with 500 μL for 2 days at 4°C, on a roller Troubleshooting 2 and 3. Note: Antibody mix can be stored at 4°C after incubations and reused, at least, 2x with different samples. 11.Wash samples with 1 mL washing solution, for 1 day at RT, on a roller:a.Change the solution at least 2x during this period. Wash samples with 1 mL washing solution, for 1 day at RT, on a roller:a.Change the solution at least 2x during this period. a.Change the solution at least 2x during this period. Change the solution at least 2x during this period. 12.Dilute the secondary antibody in WMB and incubate the sample with 500 μL for 2 days at 4°C, on a roller Troubleshooting 2 and 3. Dilute the secondary antibody in WMB and incubate the sample with 500 μL for 2 days at 4°C, on a roller Troubleshooting 2 and 3. Note: Antibody mix can be stored at 4°C after incubations and reused, at least, 2x with different samples. Optional: TO-PRO-3 can be added in this incubation; if so, add 1 extra day to the incubation time. 13.Wash samples with 1 mL of washing solution, for 1 day at RT, on a roller:a.Change the solution at least 2x during this period Troubleshooting 2 and 3.b.For samples with TO-PRO-3 staining, increase washing time to 1.5 days and change the solution at least 4x during this period. Wash samples with 1 mL of washing solution, for 1 day at RT, on a roller:a.Change the solution at least 2x during this period Troubleshooting 2 and 3.b.For samples with TO-PRO-3 staining, increase washing time to 1.5 days and change the solution at least 4x during this period. a.Change the solution at least 2x during this period Troubleshooting 2 and 3. Change the solution at least 2x during this period Troubleshooting 2 and 3. b.For samples with TO-PRO-3 staining, increase washing time to 1.5 days and change the solution at least 4x during this period. For samples with TO-PRO-3 staining, increase washing time to 1.5 days and change the solution at least 4x during this period. 14.Place the samples in 1 mL of 4% PFA and incubate for 5 min at RT Troubleshooting 4. Place the samples in 1 mL of 4% PFA and incubate for 5 min at RT Troubleshooting 4. 15.After fixation, remove the 4% PFA solution and wash the samples in 1 mL washing solution, 3x for 5 min each, at RT and on a roller. After fixation, remove the 4% PFA solution and wash the samples in 1 mL washing solution, 3x for 5 min each, at RT and on a roller. Optional: As an alternative to the above section, for samples where immunofluorescence staining is not needed but nuclear staining is desired, the following steps can be done after the end of the sample preparation section. 16.After SC dissection (Step 8), permeabilize the samples in washing solution for 1 day at RT, on a roller. After SC dissection (Step 8), permeabilize the samples in washing solution for 1 day at RT, on a roller. 17.Dilute TO-PRO-3 in washing solution and incubate for 2 days at RT. Dilute TO-PRO-3 in washing solution and incubate for 2 days at RT. Note: Although not tested due to our light sheet systems’ specifications, other nuclear dyes, like DAPI, have to be optimized but could be used as alternatives to TO-PRO-3. 18.Wash samples with washing solution, for 1.5 days at RT, on a roller:a.Change the solution at least 3x during this period. Wash samples with washing solution, for 1.5 days at RT, on a roller:a.Change the solution at least 3x during this period. a.Change the solution at least 3x during this period. Change the solution at least 3x during this period. Sample clearing and visualization | Scale solutions Timing: 4 days Despite the small girth of the zebrafish SC, in comparison to rodent models, its opaqueness hinders the imaging of structures that reside within the tissue, like blood vessels. To visualize the full vascular network of the zebrafish SC, we adapted a clearing protocol using Scale solutions,2,3 which transparentizes the tissue in less than a week, while keeping its integrity. This protocol describes an additional optimization of the protocol used in Ribeiro et al.1 and can be started right away after SC dissection or following whole-mount tissue staining. Note: For all incubations and washes, sample tubes samples were wrapped in aluminum foil while in the incubator, to protect them from light. Use of a roller during the incubations is optional and, in that case, the samples should be stored in a cylindrical opaque container while on the roller. CRITICAL: Samples can be hidden inside the cap of the 1.5 mL tubes or can be aspirated while switching the solutions. To avoid damaging or losing samples, always make sure they are visible and inside the solution, before gently removing the liquid. Ensure that the samples are submerged and that tube caps are well closed before starting incubations. 19.Remove the solution and start the clearing protocol (Figure 2A) by incubating the samples in 1 mL of Scale A2, at 37°C for 2 days. Remove the solution and start the clearing protocol (Figure 2A) by incubating the samples in 1 mL of Scale A2, at 37°C for 2 days. Optional: To improve clearing, Scale A2 solution can be switched daily during incubation. 20.Remove the Scale A2 solution from the samples and incubate the samples in 1 mL of Scale S4, at 37°C for 2 days. Remove the Scale A2 solution from the samples and incubate the samples in 1 mL of Scale S4, at 37°C for 2 days. Optional: To improve clearing, Scale S4 solution can be changed daily during incubation. 21.Keep samples at 4°C, protected from light, until acquisition. Keep samples at 4°C, protected from light, until acquisition. Pause point: Samples can be stored, at least, 1 week between the end of the protocol and acquisition. However, it is better to acquire the samples as soon as possible, to prevent the deterioration of the fluorescent proteins/fluorophores signal. Clearing protocol using Scale solutions and sample setup for acquisition (A) Representative kdrl transgenic line sample appearance, labeling blood vessels, before clearing (naïve sample, in 1X PBS) and over time, following Scale A2 and Scale S4 incubation. After incubation with Scale S4, native signal of kdrl:EGFP is confirmed in a fluorescent stereoscope before acquisition. (B) Sample mounting for whole-mount acquisition, representative view of sample positioning and final maximum projected view of the spinal cord’s whole vascular network in a kdrl:HRAS-mCherry transgenic fish. Scale bars: Top Panel – 1 mm; Bottom Panel - 50 μm. After sample clearing, it is necessary to confirm the quality of the sample (e.g., if it is fully transparent, if the native or amplified signal is visible, etc.) and determine the preferred mounting strategy for the sample before proceeding with the acquisition, in this case, using a Zeiss Lightsheet Z.1 system. 22.Before acquisition, confirm the presence of fluorophore/staining signal in a fluorescence stereoscope and trim the sample, if necessary:a.Place the SC in a petri dish, together with some Scale S4 to keep the sample from drying and check the sample’s signal and transparency.Note: If the sample still maintains an opaque look, renew the Scale S4 solution and incubate it for another day at 37°C Troubleshooting 5.b.In injured samples, trim most of the rostral part of the SC before the injury using a scalpel.Note: In vertical light sheet systems and in the case of injured samples, this trimming helps with the stabilization of the sample inside the capillary during acquisition Troubleshooting 6.CRITICAL: If this step is skipped and if a big portion of the SC needs to be extruded to reach the region of interest, it is possible that the sample will fall off and the acquisition will need to be stopped. Additionally, if the sample is not pulled back to the capillary in time, the cleared SC might be lost inside the imaging chamber’s medium.c.In the case where the region to be imaged is covered with melanophores, secure one edge of the SC with a forceps and, with another forceps, gently scrape off the pigmented cells.Note: As mentioned in the Sample Preparation Section, some SCs have a high coverage of pigmented cells on the dorsal side. These cells can remain after the dissection of the SC and may create a barrier for the light sheets crossing the sample during acquisition. Therefore, their removal might be necessary to ensure the best acquisition possible, but caution must be taken to preserve the sample’s integrity during this process.d.Return the sample to the tube filled with Scale S4 and store it at 4°C. Before acquisition, confirm the presence of fluorophore/staining signal in a fluorescence stereoscope and trim the sample, if necessary:a.Place the SC in a petri dish, together with some Scale S4 to keep the sample from drying and check the sample’s signal and transparency.Note: If the sample still maintains an opaque look, renew the Scale S4 solution and incubate it for another day at 37°C Troubleshooting 5.b.In injured samples, trim most of the rostral part of the SC before the injury using a scalpel.Note: In vertical light sheet systems and in the case of injured samples, this trimming helps with the stabilization of the sample inside the capillary during acquisition Troubleshooting 6.CRITICAL: If this step is skipped and if a big portion of the SC needs to be extruded to reach the region of interest, it is possible that the sample will fall off and the acquisition will need to be stopped. Additionally, if the sample is not pulled back to the capillary in time, the cleared SC might be lost inside the imaging chamber’s medium.c.In the case where the region to be imaged is covered with melanophores, secure one edge of the SC with a forceps and, with another forceps, gently scrape off the pigmented cells.Note: As mentioned in the Sample Preparation Section, some SCs have a high coverage of pigmented cells on the dorsal side. These cells can remain after the dissection of the SC and may create a barrier for the light sheets crossing the sample during acquisition. Therefore, their removal might be necessary to ensure the best acquisition possible, but caution must be taken to preserve the sample’s integrity during this process.d.Return the sample to the tube filled with Scale S4 and store it at 4°C. a.Place the SC in a petri dish, together with some Scale S4 to keep the sample from drying and check the sample’s signal and transparency.Note: If the sample still maintains an opaque look, renew the Scale S4 solution and incubate it for another day at 37°C Troubleshooting 5. Place the SC in a petri dish, together with some Scale S4 to keep the sample from drying and check the sample’s signal and transparency.Note: If the sample still maintains an opaque look, renew the Scale S4 solution and incubate it for another day at 37°C Troubleshooting 5. Note: If the sample still maintains an opaque look, renew the Scale S4 solution and incubate it for another day at 37°C Troubleshooting 5. b.In injured samples, trim most of the rostral part of the SC before the injury using a scalpel.Note: In vertical light sheet systems and in the case of injured samples, this trimming helps with the stabilization of the sample inside the capillary during acquisition Troubleshooting 6.CRITICAL: If this step is skipped and if a big portion of the SC needs to be extruded to reach the region of interest, it is possible that the sample will fall off and the acquisition will need to be stopped. Additionally, if the sample is not pulled back to the capillary in time, the cleared SC might be lost inside the imaging chamber’s medium. In injured samples, trim most of the rostral part of the SC before the injury using a scalpel.Note: In vertical light sheet systems and in the case of injured samples, this trimming helps with the stabilization of the sample inside the capillary during acquisition Troubleshooting 6.CRITICAL: If this step is skipped and if a big portion of the SC needs to be extruded to reach the region of interest, it is possible that the sample will fall off and the acquisition will need to be stopped. Additionally, if the sample is not pulled back to the capillary in time, the cleared SC might be lost inside the imaging chamber’s medium. Note: In vertical light sheet systems and in the case of injured samples, this trimming helps with the stabilization of the sample inside the capillary during acquisition Troubleshooting 6. CRITICAL: If this step is skipped and if a big portion of the SC needs to be extruded to reach the region of interest, it is possible that the sample will fall off and the acquisition will need to be stopped. Additionally, if the sample is not pulled back to the capillary in time, the cleared SC might be lost inside the imaging chamber’s medium. c.In the case where the region to be imaged is covered with melanophores, secure one edge of the SC with a forceps and, with another forceps, gently scrape off the pigmented cells.Note: As mentioned in the Sample Preparation Section, some SCs have a high coverage of pigmented cells on the dorsal side. These cells can remain after the dissection of the SC and may create a barrier for the light sheets crossing the sample during acquisition. Therefore, their removal might be necessary to ensure the best acquisition possible, but caution must be taken to preserve the sample’s integrity during this process. In the case where the region to be imaged is covered with melanophores, secure one edge of the SC with a forceps and, with another forceps, gently scrape off the pigmented cells.Note: As mentioned in the Sample Preparation Section, some SCs have a high coverage of pigmented cells on the dorsal side. These cells can remain after the dissection of the SC and may create a barrier for the light sheets crossing the sample during acquisition. Therefore, their removal might be necessary to ensure the best acquisition possible, but caution must be taken to preserve the sample’s integrity during this process. Note: As mentioned in the Sample Preparation Section, some SCs have a high coverage of pigmented cells on the dorsal side. These cells can remain after the dissection of the SC and may create a barrier for the light sheets crossing the sample during acquisition. Therefore, their removal might be necessary to ensure the best acquisition possible, but caution must be taken to preserve the sample’s integrity during this process. d.Return the sample to the tube filled with Scale S4 and store it at 4°C. Return the sample to the tube filled with Scale S4 and store it at 4°C. 23.For light sheet microscopy acquisition on a Zeiss Lightsheet Z.1 system:a.Mount the SCs in size 1 capillaries (Figure 2B).b.Attach the capillary to the system’s sample adapter, place it on the microscope and lower the setup into the Scale S4 filled chamber.c.Place the sample in front of the system’s objective.d.On the microscope’s software, locate the sample and adjust the focus and positioning controls using the “Locate Capillary” view.e.Using the plunger, gently extrude the region of interest (e.g., injury site) from the capillary, while keeping most of the SC inside for stability.f.Place the sample in the center of the view and switch to “Locate Sample”.g.Adjust the focus and positioning controls until the region of interest comes into focus and is in the center of the field.h.Go to acquisition, set up the acquisition parameters on the software and start sample acquisition.Note: Specialized training in these types of systems, provided by institutional or Zeiss technical staff, is crucial to ensure the best practices and results for sample acquisition. A representative overview of the Zeiss software user interface is shown in Yu et al.10i.After acquisition, return the sample to its tube and store it at 4°C, protected from light. For light sheet microscopy acquisition on a Zeiss Lightsheet Z.1 system:a.Mount the SCs in size 1 capillaries (Figure 2B).b.Attach the capillary to the system’s sample adapter, place it on the microscope and lower the setup into the Scale S4 filled chamber.c.Place the sample in front of the system’s objective.d.On the microscope’s software, locate the sample and adjust the focus and positioning controls using the “Locate Capillary” view.e.Using the plunger, gently extrude the region of interest (e.g., injury site) from the capillary, while keeping most of the SC inside for stability.f.Place the sample in the center of the view and switch to “Locate Sample”.g.Adjust the focus and positioning controls until the region of interest comes into focus and is in the center of the field.h.Go to acquisition, set up the acquisition parameters on the software and start sample acquisition.Note: Specialized training in these types of systems, provided by institutional or Zeiss technical staff, is crucial to ensure the best practices and results for sample acquisition. A representative overview of the Zeiss software user interface is shown in Yu et al.10i.After acquisition, return the sample to its tube and store it at 4°C, protected from light. a.Mount the SCs in size 1 capillaries (Figure 2B). Mount the SCs in size 1 capillaries (Figure 2B). b.Attach the capillary to the system’s sample adapter, place it on the microscope and lower the setup into the Scale S4 filled chamber. Attach the capillary to the system’s sample adapter, place it on the microscope and lower the setup into the Scale S4 filled chamber. c.Place the sample in front of the system’s objective. Place the sample in front of the system’s objective. d.On the microscope’s software, locate the sample and adjust the focus and positioning controls using the “Locate Capillary” view. On the microscope’s software, locate the sample and adjust the focus and positioning controls using the “Locate Capillary” view. e.Using the plunger, gently extrude the region of interest (e.g., injury site) from the capillary, while keeping most of the SC inside for stability. Using the plunger, gently extrude the region of interest (e.g., injury site) from the capillary, while keeping most of the SC inside for stability. f.Place the sample in the center of the view and switch to “Locate Sample”. Place the sample in the center of the view and switch to “Locate Sample”. g.Adjust the focus and positioning controls until the region of interest comes into focus and is in the center of the field. Adjust the focus and positioning controls until the region of interest comes into focus and is in the center of the field. h.Go to acquisition, set up the acquisition parameters on the software and start sample acquisition.Note: Specialized training in these types of systems, provided by institutional or Zeiss technical staff, is crucial to ensure the best practices and results for sample acquisition. A representative overview of the Zeiss software user interface is shown in Yu et al.10 Go to acquisition, set up the acquisition parameters on the software and start sample acquisition.Note: Specialized training in these types of systems, provided by institutional or Zeiss technical staff, is crucial to ensure the best practices and results for sample acquisition. A representative overview of the Zeiss software user interface is shown in Yu et al.10 Note: Specialized training in these types of systems, provided by institutional or Zeiss technical staff, is crucial to ensure the best practices and results for sample acquisition. A representative overview of the Zeiss software user interface is shown in Yu et al.10 i.After acquisition, return the sample to its tube and store it at 4°C, protected from light. After acquisition, return the sample to its tube and store it at 4°C, protected from light. Alternative downstream applications | histology and staining Timing: 5 days Samples that were cleared using Scale solutions can be restored (descaled) and used for downstream applications, as described in Hama et al.3 In this segment, we describe the protocol used for preparing and embedding cleared unstained SCs and the staining protocols done in these cryosectioned samples. Note: Reagents for the sucrose and gelatin solutions are mentioned in the materials and equipment section. The following clearing reversion and sample inclusion protocol was employed in cleared SCs. 24.Remove the Scale S4 solution and wash sample in 1 mL of 1X PBS, 3x for 5 min each, at RT in a shaker. Remove the Scale S4 solution and wash sample in 1 mL of 1X PBS, 3x for 5 min each, at RT in a shaker. 25.Incubate samples in 1 mL of 1X PBS, at 4°C for 1 day, to partially revert the clearing. Incubate samples in 1 mL of 1X PBS, at 4°C for 1 day, to partially revert the clearing. 26.Equilibrate the samples in sucrose solutions, first in 1 mL of 15% sucrose solution, followed by 1 mL of 30% sucrose solution:a.Switch sucrose solutions when SC is no longer floating on the top portion of the solution. This can take up to 12 h but, if needed, the sample can be left in the solution for 24 h.b.Leave the sample in 30% sucrose overnight. Equilibrate the samples in sucrose solutions, first in 1 mL of 15% sucrose solution, followed by 1 mL of 30% sucrose solution:a.Switch sucrose solutions when SC is no longer floating on the top portion of the solution. This can take up to 12 h but, if needed, the sample can be left in the solution for 24 h.b.Leave the sample in 30% sucrose overnight. a.Switch sucrose solutions when SC is no longer floating on the top portion of the solution. This can take up to 12 h but, if needed, the sample can be left in the solution for 24 h. Switch sucrose solutions when SC is no longer floating on the top portion of the solution. This can take up to 12 h but, if needed, the sample can be left in the solution for 24 h. b.Leave the sample in 30% sucrose overnight. Leave the sample in 30% sucrose overnight. 27.Incubate the samples in a 7.5% gelatin solution for 30 min at 37°C, mount the samples in cryomolds:a.Prepare the cryomolds with a layer of 7.5% gelatin and place them at 4 °C at the same time as the samples are in gelatin. Incubate the samples in a 7.5% gelatin solution for 30 min at 37°C, mount the samples in cryomolds:a.Prepare the cryomolds with a layer of 7.5% gelatin and place them at 4 °C at the same time as the samples are in gelatin. a.Prepare the cryomolds with a layer of 7.5% gelatin and place them at 4 °C at the same time as the samples are in gelatin. Prepare the cryomolds with a layer of 7.5% gelatin and place them at 4 °C at the same time as the samples are in gelatin. 28.With the help of a forceps, position the samples in the layer of gelatin, with the rostral side to the left and dorsal side up and place the sample for 5 min at 4°C. With the help of a forceps, position the samples in the layer of gelatin, with the rostral side to the left and dorsal side up and place the sample for 5 min at 4°C. 29.Gently add another layer of gelatin on top to cover the whole sample and place it for, at least, 30 min at 4°C and snap freeze them using chilled Isopentane.Note: Before freezing and using a thin permanent pen, label the gelatin block with an ID number and a line along the sample to indicate its position. If unmolded, place an identifying mark on the right side (sectioning surface) of the block.a.Place the frozen samples in labeled foil envelopes.b.Temporarily store samples and transport them in dry ice.c.Long-term storage of samples is done at −80°C until sectioned.Pause point: After sectioning (12 μm-thick transversal and longitudinal slices), slides were kept in slide boxes at −20°C until needed, for at least 2 months.Note: Samples were sectioned in twin slides. For longitudinal sections, a total of three slides were made per sample. Sections were placed, sequentially, in each slide one at a time (section 1 on slide 1; section 2 on slide 2; section 3 on slide 3; section 4 on slide 1 and so on) until all the sample was sectioned. For transversal sections, twin slides were also done but with 5 sets, each with 3 slides of 12 sections each. Each slide of a set therefore represents one specific regions of the sample, from slide 1 of each set with more rostral sections to slide 3 representing more caudal sections. In this way, for each orientation, we can have the same representative regions of the entire SC in each slide, which can be compared when doing different stainings.Sectioned samples, both reversed and naïve (uncleared SCs, kept in 1X PBS) were used in the following immunofluorescence staining protocol:Note: Antibodies and DAPI concentrations are mentioned in the key resources table section.Note: All washes were performed in a foil-covered staining jar containing 50 mL of solution with gentle agitation (maximum 20 rpm) on a shaker. Prepare in advance enough washing solution (0.3% Triton X-100 in 1X PBS) for this protocol (400 mL per staining jar).CRITICAL: Always keep the slides protected from light, or with minimal exposure to light during the changes of solution, to preserve the fluorophore signal. Gently add another layer of gelatin on top to cover the whole sample and place it for, at least, 30 min at 4°C and snap freeze them using chilled Isopentane.Note: Before freezing and using a thin permanent pen, label the gelatin block with an ID number and a line along the sample to indicate its position. If unmolded, place an identifying mark on the right side (sectioning surface) of the block.a.Place the frozen samples in labeled foil envelopes.b.Temporarily store samples and transport them in dry ice.c.Long-term storage of samples is done at −80°C until sectioned.Pause point: After sectioning (12 μm-thick transversal and longitudinal slices), slides were kept in slide boxes at −20°C until needed, for at least 2 months.Note: Samples were sectioned in twin slides. For longitudinal sections, a total of three slides were made per sample. Sections were placed, sequentially, in each slide one at a time (section 1 on slide 1; section 2 on slide 2; section 3 on slide 3; section 4 on slide 1 and so on) until all the sample was sectioned. For transversal sections, twin slides were also done but with 5 sets, each with 3 slides of 12 sections each. Each slide of a set therefore represents one specific regions of the sample, from slide 1 of each set with more rostral sections to slide 3 representing more caudal sections. In this way, for each orientation, we can have the same representative regions of the entire SC in each slide, which can be compared when doing different stainings.Sectioned samples, both reversed and naïve (uncleared SCs, kept in 1X PBS) were used in the following immunofluorescence staining protocol:Note: Antibodies and DAPI concentrations are mentioned in the key resources table section.Note: All washes were performed in a foil-covered staining jar containing 50 mL of solution with gentle agitation (maximum 20 rpm) on a shaker. Prepare in advance enough washing solution (0.3% Triton X-100 in 1X PBS) for this protocol (400 mL per staining jar).CRITICAL: Always keep the slides protected from light, or with minimal exposure to light during the changes of solution, to preserve the fluorophore signal. Note: Before freezing and using a thin permanent pen, label the gelatin block with an ID number and a line along the sample to indicate its position. If unmolded, place an identifying mark on the right side (sectioning surface) of the block. a.Place the frozen samples in labeled foil envelopes. Place the frozen samples in labeled foil envelopes. b.Temporarily store samples and transport them in dry ice. Temporarily store samples and transport them in dry ice. c.Long-term storage of samples is done at −80°C until sectioned.Pause point: After sectioning (12 μm-thick transversal and longitudinal slices), slides were kept in slide boxes at −20°C until needed, for at least 2 months.Note: Samples were sectioned in twin slides. For longitudinal sections, a total of three slides were made per sample. Sections were placed, sequentially, in each slide one at a time (section 1 on slide 1; section 2 on slide 2; section 3 on slide 3; section 4 on slide 1 and so on) until all the sample was sectioned. For transversal sections, twin slides were also done but with 5 sets, each with 3 slides of 12 sections each. Each slide of a set therefore represents one specific regions of the sample, from slide 1 of each set with more rostral sections to slide 3 representing more caudal sections. In this way, for each orientation, we can have the same representative regions of the entire SC in each slide, which can be compared when doing different stainings.Sectioned samples, both reversed and naïve (uncleared SCs, kept in 1X PBS) were used in the following immunofluorescence staining protocol:Note: Antibodies and DAPI concentrations are mentioned in the key resources table section.Note: All washes were performed in a foil-covered staining jar containing 50 mL of solution with gentle agitation (maximum 20 rpm) on a shaker. Prepare in advance enough washing solution (0.3% Triton X-100 in 1X PBS) for this protocol (400 mL per staining jar).CRITICAL: Always keep the slides protected from light, or with minimal exposure to light during the changes of solution, to preserve the fluorophore signal. Long-term storage of samples is done at −80°C until sectioned.Pause point: After sectioning (12 μm-thick transversal and longitudinal slices), slides were kept in slide boxes at −20°C until needed, for at least 2 months.Note: Samples were sectioned in twin slides. For longitudinal sections, a total of three slides were made per sample. Sections were placed, sequentially, in each slide one at a time (section 1 on slide 1; section 2 on slide 2; section 3 on slide 3; section 4 on slide 1 and so on) until all the sample was sectioned. For transversal sections, twin slides were also done but with 5 sets, each with 3 slides of 12 sections each. Each slide of a set therefore represents one specific regions of the sample, from slide 1 of each set with more rostral sections to slide 3 representing more caudal sections. In this way, for each orientation, we can have the same representative regions of the entire SC in each slide, which can be compared when doing different stainings. Pause point: After sectioning (12 μm-thick transversal and longitudinal slices), slides were kept in slide boxes at −20°C until needed, for at least 2 months. Note: Samples were sectioned in twin slides. For longitudinal sections, a total of three slides were made per sample. Sections were placed, sequentially, in each slide one at a time (section 1 on slide 1; section 2 on slide 2; section 3 on slide 3; section 4 on slide 1 and so on) until all the sample was sectioned. For transversal sections, twin slides were also done but with 5 sets, each with 3 slides of 12 sections each. Each slide of a set therefore represents one specific regions of the sample, from slide 1 of each set with more rostral sections to slide 3 representing more caudal sections. In this way, for each orientation, we can have the same representative regions of the entire SC in each slide, which can be compared when doing different stainings. Sectioned samples, both reversed and naïve (uncleared SCs, kept in 1X PBS) were used in the following immunofluorescence staining protocol:Note: Antibodies and DAPI concentrations are mentioned in the key resources table section.Note: All washes were performed in a foil-covered staining jar containing 50 mL of solution with gentle agitation (maximum 20 rpm) on a shaker. Prepare in advance enough washing solution (0.3% Triton X-100 in 1X PBS) for this protocol (400 mL per staining jar).CRITICAL: Always keep the slides protected from light, or with minimal exposure to light during the changes of solution, to preserve the fluorophore signal. Note: Antibodies and DAPI concentrations are mentioned in the key resources table section. Note: All washes were performed in a foil-covered staining jar containing 50 mL of solution with gentle agitation (maximum 20 rpm) on a shaker. Prepare in advance enough washing solution (0.3% Triton X-100 in 1X PBS) for this protocol (400 mL per staining jar). CRITICAL: Always keep the slides protected from light, or with minimal exposure to light during the changes of solution, to preserve the fluorophore signal. 30.Thaw slides at RT for 15 min inside a slide box:a.At the same time, warm 1X PBS at 37°C. Thaw slides at RT for 15 min inside a slide box:a.At the same time, warm 1X PBS at 37°C. a.At the same time, warm 1X PBS at 37°C. At the same time, warm 1X PBS at 37°C. 31.Put slides in a staining jar and incubate with warmed 1X PBS, inside a bath at 37°C, 4x for 5 min to remove the gelatin from the sectioned samples. Put slides in a staining jar and incubate with warmed 1X PBS, inside a bath at 37°C, 4x for 5 min to remove the gelatin from the sectioned samples. 32.Discard 1X PBS and permeabilize sections in 0.3% Triton X-100 in 1X PBS, for 15 min with gentle agitation. Discard 1X PBS and permeabilize sections in 0.3% Triton X-100 in 1X PBS, for 15 min with gentle agitation. 33.Clean the slides, removing as much liquid as possible, and delimit an area surrounding the samples using a pap pen. Clean the slides, removing as much liquid as possible, and delimit an area surrounding the samples using a pap pen. 34.Incubate slides in 300 μL of blocking solution (1% BSA/0.1% Triton X-100 in 1X PBS) for 2 h at RT. Incubate slides in 300 μL of blocking solution (1% BSA/0.1% Triton X-100 in 1X PBS) for 2 h at RT. CRITICAL: Make sure that the liquid covers all the sections and that it does not go over the delimited area. 35.Switch to primary antibody solution and incubate at 4°C overnight:a.Prepare the primary antibody solution by diluting the primary antibodies in blocking solution.Note: You can prepare the primary antibody solution during the blocking incubation, keeping it at 4°C until needed.b.Prepare a slide box with damp tissue paper with Milli-Q water in the bottom to create a humidified chamber for sample incubation.c.Clean slides, removing as much liquid as possible, and place them in the slide box.Note: If needed, delimit the sample area again with a pap pen.d.Add 100 μL per slide of primary antibody solution and cover the slides with Parafilm sheets, spanning all the sections, or with a coverslip. Switch to primary antibody solution and incubate at 4°C overnight:a.Prepare the primary antibody solution by diluting the primary antibodies in blocking solution.Note: You can prepare the primary antibody solution during the blocking incubation, keeping it at 4°C until needed.b.Prepare a slide box with damp tissue paper with Milli-Q water in the bottom to create a humidified chamber for sample incubation.c.Clean slides, removing as much liquid as possible, and place them in the slide box.Note: If needed, delimit the sample area again with a pap pen.d.Add 100 μL per slide of primary antibody solution and cover the slides with Parafilm sheets, spanning all the sections, or with a coverslip. a.Prepare the primary antibody solution by diluting the primary antibodies in blocking solution.Note: You can prepare the primary antibody solution during the blocking incubation, keeping it at 4°C until needed. Prepare the primary antibody solution by diluting the primary antibodies in blocking solution.Note: You can prepare the primary antibody solution during the blocking incubation, keeping it at 4°C until needed. Note: You can prepare the primary antibody solution during the blocking incubation, keeping it at 4°C until needed. b.Prepare a slide box with damp tissue paper with Milli-Q water in the bottom to create a humidified chamber for sample incubation. Prepare a slide box with damp tissue paper with Milli-Q water in the bottom to create a humidified chamber for sample incubation. c.Clean slides, removing as much liquid as possible, and place them in the slide box.Note: If needed, delimit the sample area again with a pap pen. Clean slides, removing as much liquid as possible, and place them in the slide box.Note: If needed, delimit the sample area again with a pap pen. Note: If needed, delimit the sample area again with a pap pen. d.Add 100 μL per slide of primary antibody solution and cover the slides with Parafilm sheets, spanning all the sections, or with a coverslip. Add 100 μL per slide of primary antibody solution and cover the slides with Parafilm sheets, spanning all the sections, or with a coverslip. 36.On the next day, wash the samples in 0.3% Triton X-100 in 1X PBS, 2x for 10 min with gentle agitation on a shaker.a.To remove the Parafilm sheet covering the slide, grab one of its corners, gently lift it. Then, place the slide on the staining jar to start the washes.CRITICAL: If coverslips are used during the primary antibody incubation, extra care is needed to keep the integrity of the samples.b.To remove the coverslip, grab and place the slide vertically and wait for the coverslip to slide off, without manually forcing it. If this does not happen:i.If the coverslip only partially slides off from the slide, dip it in the permeabilizing solution.ii.In case the coverslip does not move from the slide, do the first wash with the coverslip on.c.Afterward, place the slide vertically and wait for the coverslip to slide off. Then, proceed with the washing step. On the next day, wash the samples in 0.3% Triton X-100 in 1X PBS, 2x for 10 min with gentle agitation on a shaker.a.To remove the Parafilm sheet covering the slide, grab one of its corners, gently lift it. Then, place the slide on the staining jar to start the washes.CRITICAL: If coverslips are used during the primary antibody incubation, extra care is needed to keep the integrity of the samples.b.To remove the coverslip, grab and place the slide vertically and wait for the coverslip to slide off, without manually forcing it. If this does not happen:i.If the coverslip only partially slides off from the slide, dip it in the permeabilizing solution.ii.In case the coverslip does not move from the slide, do the first wash with the coverslip on.c.Afterward, place the slide vertically and wait for the coverslip to slide off. Then, proceed with the washing step. a.To remove the Parafilm sheet covering the slide, grab one of its corners, gently lift it. Then, place the slide on the staining jar to start the washes.CRITICAL: If coverslips are used during the primary antibody incubation, extra care is needed to keep the integrity of the samples. To remove the Parafilm sheet covering the slide, grab one of its corners, gently lift it. Then, place the slide on the staining jar to start the washes.CRITICAL: If coverslips are used during the primary antibody incubation, extra care is needed to keep the integrity of the samples. CRITICAL: If coverslips are used during the primary antibody incubation, extra care is needed to keep the integrity of the samples. b.To remove the coverslip, grab and place the slide vertically and wait for the coverslip to slide off, without manually forcing it. If this does not happen:i.If the coverslip only partially slides off from the slide, dip it in the permeabilizing solution.ii.In case the coverslip does not move from the slide, do the first wash with the coverslip on. To remove the coverslip, grab and place the slide vertically and wait for the coverslip to slide off, without manually forcing it. If this does not happen:i.If the coverslip only partially slides off from the slide, dip it in the permeabilizing solution.ii.In case the coverslip does not move from the slide, do the first wash with the coverslip on. i.If the coverslip only partially slides off from the slide, dip it in the permeabilizing solution. If the coverslip only partially slides off from the slide, dip it in the permeabilizing solution. ii.In case the coverslip does not move from the slide, do the first wash with the coverslip on. In case the coverslip does not move from the slide, do the first wash with the coverslip on. c.Afterward, place the slide vertically and wait for the coverslip to slide off. Then, proceed with the washing step. Afterward, place the slide vertically and wait for the coverslip to slide off. Then, proceed with the washing step. 37.Incubate samples in secondary antibody solution, for 2 h at RT, inside a closed slide box:a.Prepare the secondary antibody solution by diluting DAPI and the secondary antibodies in blocking solution.Note: You can prepare the secondary antibody solution during the washing steps, keeping it at 4°C and protected from light until needed.b.Clean slides, removing as much liquid as possible, and place them in the slide box.Note: If needed, delimit the sample area again with a pap pen.c.Add 300 μL per slide of secondary antibody solution. Incubate samples in secondary antibody solution, for 2 h at RT, inside a closed slide box:a.Prepare the secondary antibody solution by diluting DAPI and the secondary antibodies in blocking solution.Note: You can prepare the secondary antibody solution during the washing steps, keeping it at 4°C and protected from light until needed.b.Clean slides, removing as much liquid as possible, and place them in the slide box.Note: If needed, delimit the sample area again with a pap pen.c.Add 300 μL per slide of secondary antibody solution. a.Prepare the secondary antibody solution by diluting DAPI and the secondary antibodies in blocking solution.Note: You can prepare the secondary antibody solution during the washing steps, keeping it at 4°C and protected from light until needed. Prepare the secondary antibody solution by diluting DAPI and the secondary antibodies in blocking solution.Note: You can prepare the secondary antibody solution during the washing steps, keeping it at 4°C and protected from light until needed. Note: You can prepare the secondary antibody solution during the washing steps, keeping it at 4°C and protected from light until needed. b.Clean slides, removing as much liquid as possible, and place them in the slide box.Note: If needed, delimit the sample area again with a pap pen. Clean slides, removing as much liquid as possible, and place them in the slide box.Note: If needed, delimit the sample area again with a pap pen. Note: If needed, delimit the sample area again with a pap pen. c.Add 300 μL per slide of secondary antibody solution. Add 300 μL per slide of secondary antibody solution. 38.Wash the samples first in 0.3% Triton X-100 in 1X PBS, 4x for 10 min with gentle agitation, and afterward in 1X PBS, twice for 10 min on a shaker. Wash the samples first in 0.3% Triton X-100 in 1X PBS, 4x for 10 min with gentle agitation, and afterward in 1X PBS, twice for 10 min on a shaker. 39.To mount samples, add 100 μL Mowiol medium and place a coverslip on top. Let the slides dry at RT overnight, inside a slide box. Until acquisition on a confocal microscope, keep samples at 4°C. To mount samples, add 100 μL Mowiol medium and place a coverslip on top. Let the slides dry at RT overnight, inside a slide box. Until acquisition on a confocal microscope, keep samples at 4°C. The hematoxylin and eosin (H&E) staining,11 was performed using a classical protocol, using a twin slide of the same samples: Note: All incubations and washes were done at RT, inside a chemical hood. 40.Thaw slides at RT for 15 min inside a slide box:a.Warm 1X PBS at 37°C. Thaw slides at RT for 15 min inside a slide box:a.Warm 1X PBS at 37°C. a.Warm 1X PBS at 37°C. Warm 1X PBS at 37°C. 41.Put slides in a staining jars and incubate with warmed 1X PBS, inside a bath at 37°C, for 15 min to remove the gelatin from the sectioned samples. Put slides in a staining jars and incubate with warmed 1X PBS, inside a bath at 37°C, for 15 min to remove the gelatin from the sectioned samples. 42.Place slides in a slide support and incubate first in distilled water for 5 min, switch to Harris hematoxylin for 3 min, followed by a wash in tap water for 5 min. Place slides in a slide support and incubate first in distilled water for 5 min, switch to Harris hematoxylin for 3 min, followed by a wash in tap water for 5 min. 43.Dip slides once in 70% ethanol and then 4x in Alcoholic Eosin Y solution. Dip slides once in 70% ethanol and then 4x in Alcoholic Eosin Y solution. 44.Wash slides in increasing concentrations of ethanol (70%, 90% and in two separate containers with 100% ethanol), each for 1 min. Wash slides in increasing concentrations of ethanol (70%, 90% and in two separate containers with 100% ethanol), each for 1 min. 45.Incubate slides in Xylol for 10 min. Incubate slides in Xylol for 10 min. 46.Mount slides using Entellan new mounting medium, gently place a coverslip on top and let them dry at RT overnight, inside the chemical hood. Mount slides using Entellan new mounting medium, gently place a coverslip on top and let them dry at RT overnight, inside the chemical hood. Note: If needed, carefully dip the mounted slide in Xylol to remove excess mounting medium. 47.Acquire the samples using a digital slide scanner. Acquire the samples using a digital slide scanner. Expected outcomes Different methods have been developed and used in order to transparentize different kinds of organs and tissues, especially the Central Nervous System. The Scale protocols2,3 use aqueous-based solutions that are easy to make, with reagents that are relatively inexpensive and present in every lab. Generally, protocols using these solutions might take longer to achieve total sample clearing when compared with protocols that use organic solvent-based protocols, like DISCO variants,12,13 (1–2 weeks vs. days to 1 week, depending on the size of the sample). However, this aqueous-based approach is often less destructive to the tissue, maintaining its overall size and integrity, preserving transgenic fluorescent proteins and displaying high levels of biosafety.14 Additionally, its solutions are compatible with the light sheet systems commonly available for whole-mount imaging, whereas organic solvent-based protocols require specialized immersion objectives that most equipment do not have. With this optimized version of our clearing protocol, in less than a week, it is possible to prepare fully transparent adult zebrafish SCs that can be imaged using light sheet fluorescence microscopy (Figure 2). This allows for acquisition of the full vascular network of the samples, using kdrl transgenic lines,4,5,6 as seen in Figure 2 and in Ribeiro et al.1 For vascular quantification,1,15 the method described is more informative than the use of histological sections, as it allows the acquisition of the whole vascular network of the sample and not just representative sections of the vasculature. Additionally, whole-mount processing is often less laborious in terms of sample preparation and acquisition time, making it the preferred method. For transgenic lines where fluorophore signals are affected after 4% PFA fixation, we developed a whole-mount immunofluorescence staining protocol for transgenic signal amplification (Figure 3). In this case, intracellular EGFP from a Tg(mpeg1:EGFP) line,7 labeling microglia in uninjured SCs, is amplified after immunostaining with an anti-GFP antibody. In the unstained SC, less intense and fewer mpeg1+ cells are observed in the tissue and blood autofluorescence is also detected in the green channel, with comparable signal intensity to some mpeg1+ cells. After immunofluorescence staining, both mpeg1high and mpeg1low cells are observed in the tissue with an overall increase of the signal intensity, and blood autofluorescence signal is not detected in the green channel without an increase in image brightness. Additionally, we optimized a method for whole-mount nuclear staining using TO-PRO-3, which can be done independently (Video S1) or added in the final step of the immunofluorescent staining protocol. Immunofluorescence staining protocol for transgenic signal amplification (A) Representative whole-mount images of intracellular EGFP signal of mpeg1:EGFP transgenic spinal cord, with and without the anti-EGFP staining. Intracellular EGFP detection, in terms of cells labeled and (B) signal intensity, and separation from blood autofluorescence can be improved with staining. Scale bars - 100 μm. Video S1. Whole-mount nuclear staining with TO-PRO-3, related to Step 12 Labeling of spinal cord nuclei with TO-PRO-3 is possible in whole mount samples and is detectable after sample clearing. Scale bar: 100 μm. We show that it is also possible to retrieve further data from these samples by reusing them in immunofluorescence staining protocols, after sample cryosectioning. This allows for the reduction of the number of animals, since the same samples can be used in more than one type of experiment. An example where this may be useful is for staining axonal and glial bridges/compartments (Figure 4), often evaluated in zebrafish SC regeneration projects.16,17 Both antibodies work and recognize the targeted proteins after clearing reversion, in both transversal and longitudinal sections. Despite this, protocol optimizations might be needed for the transversal sections to ensure a homogeneous distribution of the staining throughout the SC section (e.g., more permeabilization and/or increase antibody concentration), as observed in the longitudinal ones. We also show that native fluorophore signal expressed in blood vessels, in this case nuclear mCherry,6 survives the clearing protocol, its reversion and the cryosectioning protocol. This makes possible the visualization of these transgenic-labeled cells/structures in downstream applications. Alternative application of cleared samples—Immunofluorescence protocol Staining of the axonal (anti-Acetylated Tubulin) and glial (anti-GFAP) compartments is possible in unstained descaled, cryosectioned spinal cord samples, both in transversal (left panel) and longitudinal (right panel) sections. Native kdrl:nls-mCherry transgenic signal is preserved. Scale bars - transversal samples: 50 μm; longitudinal samples: 100 μm. Limitations The method of injury used might influence the sample preparation steps.11,18 For SC compressions, the tissue can be removed from the vertebrae and kept intact as early as 1 day-post-injury (dpi). For transections, at earlier time points (< 7 dpi), it might not be possible to dissect the intact cord from the vertebral column. In this case, the sample must be maintained in the vertebrae for downstream applications and the muscle surrounding the sample/vertebrae removed thoroughly to not hinder the imaging process. The clearing protocol using Scale solutions has been tested in non-dissected sample in Ribeiro et al.1 This whole-mount protocol was only tested in a Light sheet microscopy system with a 20x clearing objective. No other conditions were tested and, thus, the protocol might have to be refined if there is an interest in using higher resolution objectives or to observe smaller structures. Downstream applications and reusage of samples might be restricted to protein-based techniques. While immunostaining can be done in cryosections of cleared samples, like observed in Figure 4, the efficacy of common stains like H&E is affected after the clearing technique described in this protocol (Figure 5). This limitation can be observed by the altered staining of white matter (outside tissue), which has a darker color when compared to that of naïve samples.11 This might occur since the acid/base characteristics of the tissue/cells are changed. Other types of staining classically used in nervous tissue (FluoroMyelin/Luxol Fast, Prussian Blue, etc.) were not tested but we do not exclude the possibility that the sample clearing protocol might affect their outcome. Additionally, it is important to note that, although the two antibodies above mentioned work in cleared reverted samples, we cannot guarantee the same for other types of antibodies. As always, these tools should be working or should be optimized in naïve samples as positive controls, tested in reverted samples and then both compared to ensure that reverted samples recapitulate the original staining. Alternative application of cleared samples—H&E staining In descaled cryosectioned samples, although overall structure of the spinal cord is maintained, the staining of the tissue is altered, with the white matter (outside tissue) having a darker color when compared to that of naïve samples. Scale bars - transversal samples: 50 μm; longitudinal samples: 100 μm. For downstream processing of the whole-mount images acquired, a strong processing unit must be available to do vascular quantification, like those done in Kugler et al. and Ribeiro et al., since image files acquired using light sheet microscopy can easily reach sizes of Gigabytes.1,15 Troubleshooting Problem 1 After extraction and sample fixation, the vertebral column (VC) gets bent/curled. After spinal cord (SC) dissection, the problem persists. Potential solution •When extracting the vertebral column from the animal, be careful not to damage the vertebrae since this might bend the SC during fixation. When extracting the vertebral column from the animal, be careful not to damage the vertebrae since this might bend the SC during fixation. •Bending of the VC/SC can happen due to muscle retraction during fixation. Remove as much muscle as possible before fixation, from both sides of the vertebral column and in between the neural arches, without damaging the SC. Bending of the VC/SC can happen due to muscle retraction during fixation. Remove as much muscle as possible before fixation, from both sides of the vertebral column and in between the neural arches, without damaging the SC. •Place samples in a horizontal position during 4% PFA fixation. Place samples in a horizontal position during 4% PFA fixation. Problem 2 After whole-mount immunostaining and during acquisition, there is nonspecific speckling/trapped staining in the SC due. Potential solution •Adjusting antibody concentrations might help remove or reduce nonspecific binding. Adjusting antibody concentrations might help remove or reduce nonspecific binding. •When the above-mentioned strategy is not viable, doing more washes after primary and/or secondary antibody incubation might help remove trapped antibodies. When the above-mentioned strategy is not viable, doing more washes after primary and/or secondary antibody incubation might help remove trapped antibodies. •Both strategies can be combined to achieve a better outcome. Both strategies can be combined to achieve a better outcome. Problem 3 After whole-mount immunostaining and during acquisition, the labeling is “trapped” in the outer layer of the SC or there is almost no signal inside the cord. Potential solution •Low antibody concentration might result in the antibody being consumed before reaching the center of the SC. Adjust antibody concentrations. Low antibody concentration might result in the antibody being consumed before reaching the center of the SC. Adjust antibody concentrations. •Poor permeabilization of the tissue might hinder antibody penetration. Adjust Triton X-100 /DMSO concentrations and/or increase antibody incubation period. Poor permeabilization of the tissue might hinder antibody penetration. Adjust Triton X-100 /DMSO concentrations and/or increase antibody incubation period. •Both strategies can be combined to achieve a better outcome. Both strategies can be combined to achieve a better outcome. •If the issue persists, additional methods19 can be used to improve antibody binding/penetration in the samples (e.g., electro-immunofluorescence20). If the issue persists, additional methods19 can be used to improve antibody binding/penetration in the samples (e.g., electro-immunofluorescence20). Problem 4 After whole-mount immunostaining and during acquisition, although the structure/cell type of interest can be detected, the sample has a lot of background signal. Potential solution •The timing of the 4% PFA fixation, at the temperatures mentioned in the protocol, has to be well controlled, since PFA over fixation might increase background. In our hands, we achieve similar results doing either 2 h at RT or overnight at 4°C. The timing of the 4% PFA fixation, at the temperatures mentioned in the protocol, has to be well controlled, since PFA over fixation might increase background. In our hands, we achieve similar results doing either 2 h at RT or overnight at 4°C. •The final fixation step of the whole-mount immunostaining protocol has to be well controlled and it might need to be reduced since, in our hands, incubating for more than 5 min increases the background signal. The final fixation step of the whole-mount immunostaining protocol has to be well controlled and it might need to be reduced since, in our hands, incubating for more than 5 min increases the background signal. •Adjusting the concentration of the BSA in the blocking and antibody solutions might help reduce the background signal. Adjusting the concentration of the BSA in the blocking and antibody solutions might help reduce the background signal. •In the case nonspecific speckling is also observed, adjusting the concentration of the antibodies during the whole-mount immunostaining, together with the above strategies, can reduce or resolve both problems. In the case nonspecific speckling is also observed, adjusting the concentration of the antibodies during the whole-mount immunostaining, together with the above strategies, can reduce or resolve both problems. •Although not tested in this protocol, other methods can be used for dealing with excessive background signal (e.g., Sudan Black B21) but may have consequences for the signal of interest. Although not tested in this protocol, other methods can be used for dealing with excessive background signal (e.g., Sudan Black B21) but may have consequences for the signal of interest. Problem 5 After the clearing protocol, when checking the sample in a fluorescent stereoscope, the labeled structures looked unfocused and the sample does not seem to be fully transparent. Potential solution •The incubations’ temperature have to be well controlled to achieve full transparency at the predicted time. The incubations’ temperature have to be well controlled to achieve full transparency at the predicted time. •If the sample still maintains an opaque look after the protocol, renew the Scale S4 solution and incubate it for another day at 37°C. If the sample still maintains an opaque look after the protocol, renew the Scale S4 solution and incubate it for another day at 37°C. •If the problem persists with other samples, the quality of the solutions might be compromised and new ones might be needed. Incubating the samples with the new solutions might help salvage them. If the problem persists with other samples, the quality of the solutions might be compromised and new ones might be needed. Incubating the samples with the new solutions might help salvage them. Problem 6 During sample acquisition in a vertical light sheet system, the sample moves/falls during acquisition. Potential solution •If the sample is moving/shaking during acquisition, pulling the sample until the area of interest if near the end of the capillary helps stabilizing it. Alternatively, lowering the acquisition speed also helps but increases acquisition time. If the sample is moving/shaking during acquisition, pulling the sample until the area of interest if near the end of the capillary helps stabilizing it. Alternatively, lowering the acquisition speed also helps but increases acquisition time. •If the sample is falling/sliding from the capillary, quickly pull the sample back to the capillary and then extrude it until the area of interest is near the end of the capillary. If the sample is falling/sliding from the capillary, quickly pull the sample back to the capillary and then extrude it until the area of interest is near the end of the capillary. •If the problem persists, the trimming of the sample might not have been sufficient and there is still a big portion of the SC outside the capillary. Alternatively, there might not be enough SC inside the capillary to stabilize the sample. If the problem persists, the trimming of the sample might not have been sufficient and there is still a big portion of the SC outside the capillary. Alternatively, there might not be enough SC inside the capillary to stabilize the sample. •Although not tested in this protocol, if the sample is too small or the trimming of the rostral part of the SC is not possible (e.g., due to experimental needs), low melting agarose can be used as a mounting medium. This might ensure the stability of the sample when the agarose-embedded SC is extruded from the capillary. As a reference for a starting point, we have tested and used 1% low melting agarose solution to mount live embryos. Although not tested in this protocol, if the sample is too small or the trimming of the rostral part of the SC is not possible (e.g., due to experimental needs), low melting agarose can be used as a mounting medium. This might ensure the stability of the sample when the agarose-embedded SC is extruded from the capillary. As a reference for a starting point, we have tested and used 1% low melting agarose solution to mount live embryos. Resource availability Lead contact Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Leonor Saúde (msaude@medicina.ulisboa.pt). Technical contact Technical questions on executing this protocol should be directed to and will be answered by the technical contact, Mariana Rebocho da Costa (mariana.costa@medicina.ulisboa.pt). Materials availability This study did not generate new unique reagents. Data and code availability This study did not generate/analyze datasets/code. Acknowledgments We would like to thank the Zebrafish and the Bioimaging Facilities and the Comparative Pathology Unit of Instituto de Medicina Molecular João Lobo Antunes (iMM-JLA) for all their advice and technical support. This research was funded by Fundação para a Ciência e a Tecnologia (FCT) (PTDC/BIA-BID/28572/2017) and by a grant from the Morton Cure Paralysis Fund. M.R.d.C. was supported by a doctoral fellowship from FCT (SFRH/BD/146839/2020). A.R. was supported by a contract from iMM-JLA and FCT (DL57/2016). R.Q. was supported by FCT, IP (BIG 2022). D.N.-S. was supported by a doctoral fellowship from FCT (SFRH/BD/138636/2018). L.S. was supported by a CEEC Individual Principal Investigator contract (2021.02253.CEECIND) from FCT. Author contributions M.R.d.C., writing – original draft, writing – review and editing, conceptualization, visualization, methodology, validation, and investigation. A.R., writing – review and editing, conceptualization, methodology, validation, supervision, and funding acquisition. R.Q., writing – review and editing and investigation. D.N.-S., writing – review and editing and investigation. L.S., writing – review and editing, supervision, and funding acquisition. Declaration of interests The authors declare no competing interests. Footnotes Supplemental information can be found online at https://doi.org/10.1016/j.xpro.2024.103491. Contributor Information Mariana Rebocho da Costa, Email: mariana.costa@medicina.ulisboa.pt. Leonor Saúde, Email: msaude@medicina.ulisboa.pt. References Associated Data Supplementary Materials Video S1. Whole-mount nuclear staining with TO-PRO-3, related to Step 12 Labeling of spinal cord nuclei with TO-PRO-3 is possible in whole mount samples and is detectable after sample clearing. Scale bar: 100 μm. Data Availability Statement This study did not generate/analyze datasets/code.